Cargando…

Regulation of dopamine transporter activity by carboxypeptidase E

BACKGROUND: The dopamine transporter (DAT) plays a critical role in terminating the action of dopamine by rapid reuptake into the presynaptic neuron. Previous studies have revealed that the DAT carboxyl terminus (DAT-CT) can directly interact with other cellular proteins and regulate DAT function an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Heping, Li, Shupeng, Wang, Min, Vukusic, Brian, Pristupa, Zdenek B, Liu, Fang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687442/
https://www.ncbi.nlm.nih.gov/pubmed/19419578
http://dx.doi.org/10.1186/1756-6606-2-10
_version_ 1782167532597149696
author Zhang, Heping
Li, Shupeng
Wang, Min
Vukusic, Brian
Pristupa, Zdenek B
Liu, Fang
author_facet Zhang, Heping
Li, Shupeng
Wang, Min
Vukusic, Brian
Pristupa, Zdenek B
Liu, Fang
author_sort Zhang, Heping
collection PubMed
description BACKGROUND: The dopamine transporter (DAT) plays a critical role in terminating the action of dopamine by rapid reuptake into the presynaptic neuron. Previous studies have revealed that the DAT carboxyl terminus (DAT-CT) can directly interact with other cellular proteins and regulate DAT function and trafficking. RESULTS: Here, we have identified that carboxypeptidase E (CPE), a prohormone processing exopeptidase and sorting receptor for the regulated secretory pathway, interacts with the DAT-CT and affects DAT function. Mammalian cell lines coexpressing CPE and DAT exhibited increased DAT-mediated dopamine uptake activity compared to cells expressing DAT alone. Moreover, coexpression of an interfering DAT-CT minigene inhibited the effects of CPE on DAT. Functional changes caused by CPE could be attributed to enhanced DAT expression and subsequent increase in DAT cell surface localization, due to decreased DAT degradation. In addition, CPE association could reduce the phosphorylation state of DAT on serine residues, potentially leading to reduced internalization, thus stabilizing plasmalemmal DAT localization. CONCLUSION: Taken together, our results reveal a novel role for CPE in the regulation of DAT trafficking and DAT-mediated DA uptake, which may provide a novel target in the treatment of dopamine-governed diseases such as drug addiction and obesity.
format Text
id pubmed-2687442
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26874422009-05-28 Regulation of dopamine transporter activity by carboxypeptidase E Zhang, Heping Li, Shupeng Wang, Min Vukusic, Brian Pristupa, Zdenek B Liu, Fang Mol Brain Research BACKGROUND: The dopamine transporter (DAT) plays a critical role in terminating the action of dopamine by rapid reuptake into the presynaptic neuron. Previous studies have revealed that the DAT carboxyl terminus (DAT-CT) can directly interact with other cellular proteins and regulate DAT function and trafficking. RESULTS: Here, we have identified that carboxypeptidase E (CPE), a prohormone processing exopeptidase and sorting receptor for the regulated secretory pathway, interacts with the DAT-CT and affects DAT function. Mammalian cell lines coexpressing CPE and DAT exhibited increased DAT-mediated dopamine uptake activity compared to cells expressing DAT alone. Moreover, coexpression of an interfering DAT-CT minigene inhibited the effects of CPE on DAT. Functional changes caused by CPE could be attributed to enhanced DAT expression and subsequent increase in DAT cell surface localization, due to decreased DAT degradation. In addition, CPE association could reduce the phosphorylation state of DAT on serine residues, potentially leading to reduced internalization, thus stabilizing plasmalemmal DAT localization. CONCLUSION: Taken together, our results reveal a novel role for CPE in the regulation of DAT trafficking and DAT-mediated DA uptake, which may provide a novel target in the treatment of dopamine-governed diseases such as drug addiction and obesity. BioMed Central 2009-05-06 /pmc/articles/PMC2687442/ /pubmed/19419578 http://dx.doi.org/10.1186/1756-6606-2-10 Text en Copyright © 2009 Zhang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zhang, Heping
Li, Shupeng
Wang, Min
Vukusic, Brian
Pristupa, Zdenek B
Liu, Fang
Regulation of dopamine transporter activity by carboxypeptidase E
title Regulation of dopamine transporter activity by carboxypeptidase E
title_full Regulation of dopamine transporter activity by carboxypeptidase E
title_fullStr Regulation of dopamine transporter activity by carboxypeptidase E
title_full_unstemmed Regulation of dopamine transporter activity by carboxypeptidase E
title_short Regulation of dopamine transporter activity by carboxypeptidase E
title_sort regulation of dopamine transporter activity by carboxypeptidase e
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687442/
https://www.ncbi.nlm.nih.gov/pubmed/19419578
http://dx.doi.org/10.1186/1756-6606-2-10
work_keys_str_mv AT zhangheping regulationofdopaminetransporteractivitybycarboxypeptidasee
AT lishupeng regulationofdopaminetransporteractivitybycarboxypeptidasee
AT wangmin regulationofdopaminetransporteractivitybycarboxypeptidasee
AT vukusicbrian regulationofdopaminetransporteractivitybycarboxypeptidasee
AT pristupazdenekb regulationofdopaminetransporteractivitybycarboxypeptidasee
AT liufang regulationofdopaminetransporteractivitybycarboxypeptidasee